Legal Representation
Attorney
Ursula B. Day
USPTO Deadlines
Next Deadline
1962 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-12-17)
Due Date
December 17, 2030
Grace Period Ends
June 17, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
33 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Jun 21, 2025 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB | Loading... |
May 31, 2025 | FIMP | P | FINAL DISPOSITION PROCESSED | Loading... |
May 31, 2025 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB | Loading... |
May 3, 2025 | OPNX | P | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | Loading... |
Apr 15, 2025 | OPNR | P | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | Loading... |
Apr 15, 2025 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | Loading... |
Mar 21, 2025 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED | Loading... |
Mar 18, 2025 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | Loading... |
Dec 17, 2024 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
Dec 17, 2024 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
Oct 29, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Oct 29, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Oct 9, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Sep 18, 2024 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Sep 16, 2024 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
Sep 16, 2024 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
Sep 16, 2024 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
Sep 16, 2024 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
Sep 12, 2024 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
Sep 12, 2024 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
Sep 12, 2024 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
Sep 10, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Sep 9, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Sep 9, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Apr 24, 2024 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
Apr 3, 2024 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
Apr 2, 2024 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
Mar 14, 2024 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
Mar 13, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Mar 11, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Nov 21, 2023 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
Nov 17, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Nov 16, 2023 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 001
Industrial chemicals; radioactive elements for scientific purposes; detergents for use in manufacture of radioactive substances; salts for industrial purposes; chemical substances for analyses in laboratories, other than for medical or veterinary purposes; diagnostic preparations, other than for medical or veterinary purposes; isotopes for industrial purposes; chemical reagents other than for medical or veterinary purposes; salts being chemical preparations, namely, industrial salts; fissionable chemical elements, namely, radioactive elements for scientific purposes; emollients for industrial purposes; enzymes for scientific purposes; dyes for scientific or research purposes; glycoprotein; immunoglobulins, being biological preparations for scientific use, other than for medical use; immunoassay reagents for scientific purposes, other than for medical use; immunological antibodies for scientific purposes, other than for medical use; biomolecule labeling kits comprising reagents for use in scientific research; laboratory reagents for scientific use; tagged antibodies for scientific use; tagged antibodies for laboratory use; monoclonal antibodies for scientific use; proteins in raw form for use in science; proteins in raw form for scientific purposes for binding antibodies other than for medical use; reagents for scientific purposes; substances for scientific use, namely, radioactive substances; universal reagents for automated test systems for scientific purposes; diagnostic reagents for scientific or research use
Class 005
Medical and veterinary preparations, namely, radioactive preparations for use in treating cancer; biological reagents for medical use; biological reagents for veterinary use; diagnostic chemical reagents for medical use; diagnostic agents for pharmaceutical use; diagnostic biomarker reagents for medical purposes; immunoassay reagents for medical use; in vitro diagnostic preparations for medical use; clinical medical reagents; diagnostic reagents for medical use; clinical diagnostic reagents for medical or veterinary purposes; reagents for use in diagnostic pregnancy tests for medical or veterinary purposes; reagents and media for medical and veterinary diagnostic purposes; reagents for microbiological analysis for medical purposes; mineral salts for medical purposes; chemical preparations for medical purposes, namely, for treatment of hormonal imbalances; chemical preparations for pharmaceutical purposes, namely, for treatment of migraines; chemical preparations for veterinary purposes, namely, chemical reagents for veterinary use; chemico-pharmaceutical preparations for the treatment of gout; disinfectants; diagnostic preparations for medical use; pharmaceutical, veterinary and sanitary preparations for treatment of tumor diseases; radioactive substances for medical purposes
Class 042
Science and technology services, namely, scientific research services; testing, authentication and quality control, namely, testing of pharmaceuticals, quality control for others; bacteriological consultation and research; consultancy in the field of pharmaceutical research; consultancy relating to laboratory testing of materials; biological research, clinical research in the field of chemotherapy and medical research; medical research laboratory services; analysis of human serum for medical research; research and development in the pharmaceutical and biotechnology fields; medical research laboratory services relating to the production of monoclonal antibodies; research and development services in the field of antibodies; pharmaceutical research and development; consultancy relating to biotechnology; biochemical analysis; biochemistry research services; biological research; microbiological testing; preparation of scientific research reports in the biotechnology field; research and development services in the field of immunology
Classification
International Classes
001
005
042